Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s

 Results Support Further Exploration of Therapeutic Potential of Lomecel-B to Slow Cognitive Decline, Improve Quality of Life for Alzheimer’s Patients

Phase 2 Trial Recently Launched With First Patient Treated

https://finance.yahoo.com/news/longeveron-publishes-peer-reviewed-study-120000534.html